US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

AI Healthcare

565.54

+14.092.56%

Number of Gainers:3

Number of Losers:1

Number of Flat:- -

PE:- -

High:576.66

Open:554.62

Low:554.62

Close:551.44

Volume:18.72M

Turnover:370.81M

Market Cap:17.50B

Float Cap:12.85B

Loading ...

Hitachi Cooling & Heating Supports Hong Kong's Net-Zero Transition with BEAM Plus-Aligned VRF Solutions

Is CRISPR Therapeutics (CRSP) Attractive After Recent Share Price Weakness And DCF Upside?

Simply Wall St.

Recursion Pharmaceuticals CFO Ben R Taylor disposes of USD 51,000 in common shares

Did Tempus AI's (TEM) Pediatric AML Registry Push into Patient Apps Just Shift Its Investment Narrative?

Simply Wall St.

Tempus AI, Blood Cancer United announce strategic collaboration

BRIEF-Tempus And Blood Cancer United® Announce Collaboration To Develop One Of The Largest Pediatric Acute Myeloid Leukemia Real-World Data Registries

Tempus and Blood Cancer United® Announce Collaboration to Develop One of the Largest Pediatric Acute Myeloid Leukemia Real-World Data Registries

THOMSON REUTERS

Rose the dog might have just heralded the age of programmable medicine - and here are the stocks that benefit

Crispr Therapeutics Completes $600 Million Convertible Notes Offering

Analysts Are Bullish on These Healthcare Stocks: Beam Therapeutics (BEAM), Pelthos Therapeutics (PTHS)

HCW Biologics Announces Positive Research Results for CAR-T Cell Therapy Manufactured Utilizing Its Commercial-Ready Proprietary Compound, HCW9206, Published in Science Advances

CRISPR Therapeutics’ CASGEVY Progress Reframes Growth And Valuation Story

Simply Wall St.

Press Release: Morningstar, Inc. Declares Quarterly Dividend of 50 Cents Per Share

Assessing Tempus AI (TEM) Valuation As New Oncology Study Highlights Clinical Impact Of Its AI Platform

Simply Wall St.

Cathie Wood Invests Over $10M in CRISPR and PAYP Stocks, Trims Stakes in TER and IONS

A Look At Recursion Pharmaceuticals (RXRX) Valuation After Q4 Beat And AI Clinical Progress

Simply Wall St.

Recursion Pharmaceuticals CEO and President Najat Khan Disposes of Common Shares

Why Tempus AI Stock Is Up Wednesday?

Benzinga_recent_news

CRSP, SOLQ: Cathie Wood’s ARK ‘Buys the Dip’ in CRISPR and Solana Staking ETF

Tempus AI study finds 12% of community oncology patients gain actionable results from advanced genomic profiling features

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK4611/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4611","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4611\",,,,,undefined,":{"symbol":"BK4611","market":"US","secType":"PLATE","nameCN":"AI Healthcare","latestPrice":565.5373,"timestamp":1774295999999,"preClose":551.4428,"halted":0,"volume":18719218,"delay":0,"changeRate":0.025559,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":14.094482,"latestTime":"03-23 16:00:00 EDT","open":554.62427,"high":576.6644,"low":554.62427,"amount":370805222.177872,"amplitude":0.039968,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1774310400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":3.659212,"peRate":-11.280084,"turnoverRate":0.026851,"increases":3,"decrements":1,"flats":0,"marketCap":17499774336,"floatMarketCap":12845193984},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4611\",,,,,undefined,":{"symbol":"BK4611","high":576.6644,"amplitude":0.039968,"preClose":551.4428,"low":554.62427,"pbRate":"3.659212","latestPrice":565.5373,"volume":18719218,"delay":0,"open":554.62427,"prevYearClose":658.3995,"prevWeekClose":551.4428,"prevMonthClose":657.8877,"prevQuarterClose":658.3995,"fiveDayClose":583.4832,"twentyDayClose":644.7672,"sixtyDayClose":704.2497,"secType":"PLATE","market":"US","turnoverRate":0.026851,"peRate":-11.280084,"marketCap":17499774336,"floatMarketCap":12845193984,"timestamp":1774295999999,"nameCN":"AI Healthcare"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4611\",,,,undefined,":{"bkCode":"BK4611","up":3,"down":1,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4611\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2621077295","title":"Hitachi Cooling & Heating Supports Hong Kong's Net-Zero Transition with BEAM Plus-Aligned VRF Solutions","url":"https://stock-news.laohu8.com/highlight/detail?id=2621077295","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621077295?lang=en_us&edition=fundamental","pubTime":"2026-03-23 18:25","pubTimestamp":1774261500,"startTime":"0","endTime":"0","summary":"HONG KONG, March 23, 2026 /PRNewswire/ -- As cities push toward net-zero emissions, Hong Kong is tightening building regulations and accelerating retrofits under the BEAM Plus framework. Higher expectations for energy performance and lower refrigerant GWP are reshaping HVAC standards. In a dense urban environment with limited plant rooms and constrained rooftops, conventional VRF systems often face installation challenges. Hitachi Cooling & Heating addresses these demands with VRF solutions designed for efficiency, flexibility, and alignment with BEAM Plus requirements.Complementing this highefficiency approach, air365 SideSmart, the world's first slim modular VRF, addresses Hong Kong's space constraints with an exclusive concept starting from just 1650×1050×420mm. A single 18HP module matches the capacity of conventional topdischarge units while occupying far less space. Its modular design allows up to four interconnected units, delivering a maximum of 72HP , along with flexible confi","market":"fut","thumbnail":"https://mma.prnewswire.com/media/2939848/Hitachi_air365_Max_Pro.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2939848/Hitachi_air365_Max_Pro.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/hitachi-cooling--heating-supports-hong-kongs-net-zero-transition-with-beam-plus-aligned-vrf-solutions-302721936.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1861558580.USD","BK4535","BK4588","BK4139","BK4556","BEAM","LU1861559042.SGD","BK4611","BK4505","BK4585"],"gpt_icon":0},{"id":"2621193707","title":"Is CRISPR Therapeutics (CRSP) Attractive After Recent Share Price Weakness And DCF Upside?","url":"https://stock-news.laohu8.com/highlight/detail?id=2621193707","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621193707?lang=en_us&edition=fundamental","pubTime":"2026-03-22 14:08","pubTimestamp":1774159694,"startTime":"0","endTime":"0","summary":"Wondering whether CRISPR Therapeutics at around US$46.24 is offering good value, or if the recent excitement is already priced in? This breakdown is designed to help you frame that question clearly.\nThe stock is up 12.2% over the past year, even though it shows a 5.1% decline over 7 days, a 13.5% decline over 30 days, and a 14.0% decline year to date. Recent trading has therefore looked quite different to the longer term picture.\nRecent headlines around CRISPR Therapeutics have focused on...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-crsp/crispr-therapeutics/news/is-crispr-therapeutics-crsp-attractive-after-recent-share-pr","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-crsp/crispr-therapeutics/news/is-crispr-therapeutics-crsp-attractive-after-recent-share-pr","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4211","LU1861559042.SGD","CRSP","BK4611","BK4588","BK4556","BK4585","FCF","LU1861558580.USD","BK4139","DCF"],"gpt_icon":0},{"id":"2620229822","title":"Recursion Pharmaceuticals CFO Ben R Taylor disposes of USD 51,000 in common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2620229822","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620229822?lang=en_us&edition=fundamental","pubTime":"2026-03-19 05:53","pubTimestamp":1773870800,"startTime":"0","endTime":"0","summary":"Ben Taylor, Chief Financial Officer at Recursion Pharmaceuticals, reported a disposition of 7,075 shares of Class A common stock at USD 3.42 per share on March 16, 2026. He also reported a disposition of 7,956 shares at USD 3.39 per share on March 17, 2026. Following the reported transactions, Taylor beneficially owned 1,180,318 shares of Class A common stock.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Recursion Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL1nThMr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Recursion Pharmaceuticals CFO Ben R Taylor disposes of USD 51,000 in common shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4548","BK4609","RXRX","BK4539","BK4611","BK4139"],"gpt_icon":0},{"id":"2620476321","title":"Did Tempus AI's (TEM) Pediatric AML Registry Push into Patient Apps Just Shift Its Investment Narrative?","url":"https://stock-news.laohu8.com/highlight/detail?id=2620476321","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620476321?lang=en_us&edition=fundamental","pubTime":"2026-03-17 22:19","pubTimestamp":1773757189,"startTime":"0","endTime":"0","summary":"Earlier this month, Blood Cancer United and Tempus AI announced a collaboration to build a comprehensive, patient-centered real-world registry for pediatric acute myeloid leukemia, using Tempus’ olivia app and Lens analytics platform to unify data, support families, and inform research.\nThis partnership, alongside new research showing Tempus’ advanced genomic profiling can uncover treatment-relevant findings missed by standard tests, highlights how the company’s AI and data tools are...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tem/tempus-ai/news/did-tempus-ais-tem-pediatric-aml-registry-push-into-patient","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tem/tempus-ai/news/did-tempus-ais-tem-pediatric-aml-registry-push-into-patient","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4611","BK4585","BK4551","BK7095","TEMT","BK4528","BK4543","LU1861558580.USD","BK4121","TEM","BK4023","BK4588","BK4587","AIYY","LU1861559042.SGD","BK4613"],"gpt_icon":1},{"id":"2620420512","title":"Tempus AI, Blood Cancer United announce strategic collaboration","url":"https://stock-news.laohu8.com/highlight/detail?id=2620420512","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620420512?lang=en_us&edition=fundamental","pubTime":"2026-03-17 21:10","pubTimestamp":1773753020,"startTime":"0","endTime":"0","summary":"Tempus AI (TEM) and Blood Cancer United announced a strategic collaboration to develop a real-world registry for pediatric acute myeloid leukemia, ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tempus-ai-blood-cancer-united-announce-strategic-collaboration-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tempus-ai-blood-cancer-united-announce-strategic-collaboration-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4211","BK4023","BK4543","BK4551","BK4587","BK4611","BK4613","BK4528","BK4121","LU1861558580.USD","LU1861559042.SGD","BK4588","TEM","TEMT","BK4585","AIYY"],"gpt_icon":0},{"id":"2620422380","title":"BRIEF-Tempus And Blood Cancer United® Announce Collaboration To Develop One Of The Largest Pediatric Acute Myeloid Leukemia Real-World Data Registries","url":"https://stock-news.laohu8.com/highlight/detail?id=2620422380","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620422380?lang=en_us&edition=fundamental","pubTime":"2026-03-17 20:34","pubTimestamp":1773750890,"startTime":"0","endTime":"0","summary":"BRIEF-Tempus And Blood Cancer United Announce Collaboration To Develop One Of The Largest Pediatric Acute Myeloid Leukemia Real-World Data RegistriesMarch 17 (Reuters) - Tempus AI Inc TEM.O:TEMPUS AND","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nTUA2NW0JK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1861559042.SGD","BK4613","LU1861558580.USD","BK4121","TEM","BK4611","TEMT"],"gpt_icon":1},{"id":"2620742470","title":"Tempus and Blood Cancer United® Announce Collaboration to Develop One of the Largest Pediatric Acute Myeloid Leukemia Real-World Data Registries","url":"https://stock-news.laohu8.com/highlight/detail?id=2620742470","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620742470?lang=en_us&edition=fundamental","pubTime":"2026-03-17 20:30","pubTimestamp":1773750600,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nTUA2NW0JK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1861559042.SGD","TEM","TEMT","BK4121","BK4611","BK4613","LU1861558580.USD"],"gpt_icon":0},{"id":"2620425297","title":"Rose the dog might have just heralded the age of programmable medicine - and here are the stocks that benefit","url":"https://stock-news.laohu8.com/highlight/detail?id=2620425297","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620425297?lang=en_us&edition=fundamental","pubTime":"2026-03-17 18:49","pubTimestamp":1773744540,"startTime":"0","endTime":"0","summary":"Software is now on the verge of eating medicine, says tech investor Eric Jackson. Pet owner Paul Conyngham  and Professor Pall Thordarson discussed the cancer vaccine given to Rose the dog on Australia's Today program.There was an incredible story from the weekend in Australia, where a tech executive designed a personalized cancer vaccine for his dog Rose. He used ChatGPT and Google's DeepFold to analyze Rose's DNA, and got a university to manufacture a vaccine. The cancer wasn't cured but was greatly reduced, improving the quality of life for his canine companion.Eric Jackson, the tech investor who is chief investment officer for EMJ Capital, talked about the investment implications, beyond the obvious that it shows off the potential for mRNA vaccine maker Moderna .\"This guy just did something that looks like the first version of programmable medicine that people have been talking about but hasn't really happened yet,\" Jackson said in a video posted on LinkedIn. \"Once AI can analyze y","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN29S564.USD","LU0823417737.USD","SG9999014906.USD","LU2506952170.USD","LU1267930490.SGD","LU0345774391.USD","LU0320765059.SGD","IE00BWXC8680.SGD","LU2471134523.USD","BK4097","LU2211815571.USD","LU1633808545.USD","MSFU","LU2362541513.USD","LU1778281490.HKD","IE00BQXX3C00.GBP","LU0871640123.AUD","LU1188199696.SGD","BK4608","LU2326559502.SGD","BK4599","LU1400636574.HKD","SG9999014898.SGD","IE00B1XK9C88.USD","IE00B19Z9505.USD","SG9999014559.SGD","IE00B19Z8X17.USD","LU2764263203.CNY","LU2065171311.SGD","SG9999015986.USD","LU0198837287.USD","LU2764262908.HKD","LU0128525689.USD","MSFO","LU0097036916.USD","BK4516","LU0158827948.USD","LU0708994859.HKD","LU2602419157.SGD","MSFW","IE00B1BXHZ80.USD","NVII","SG9999001176.SGD","BK4611","LU1839511570.USD","IE0034235303.USD","LU1815336760.USD","LU0234570918.USD","LU0708995401.HKD","IE00B775SV38.USD","SG9999002224.SGD","LU1670756490.USD","LU1003077747.HKD","LU0979878070.USD","LU0553294199.USD","LU0820561818.USD","LU1951198990.SGD","MSFD","IE00BBT3K403.USD","LU2095319765.USD","IE00BSNM7G36.USD","NVDU","BK4533","IE0034235188.USD","LU2210149790.SGD","LU0742534661.SGD","IE00BHPRN162.USD","LU1303367103.USD","LU2077746001.SGD","LU0211331839.USD","LU1629891620.HKD","NVDB","LU2148611432.USD","NVDG","LU0053666078.USD","BK4577","LU1035773651.USD","LU1989772923.USD","BK4007","LU1280957306.USD","BK4568","LU0266013472.USD","IE0009355771.USD","LU2089984988.USD","LU2237443382.USD","SG9999014880.SGD","LU1291159041.SGD","NVDS.UK","LU0689626769.HKD","LU2168564065.EUR","LU0321505868.SGD","LU1244550577.SGD","LU1153585028.USD","LU0976567544.SGD","LU2097829019.USD","LU0048573561.USD","LU0390134368.USD","LU2458330243.SGD","LU1201861249.SGD","BK4585","IE00BFSS7M15.SGD","IE00BJJMRX11.SGD","LU0320765646.SGD","LU2430703251.USD","LU1061106388.HKD","IE00BYXW3230.USD","LU0122379950.USD","LU2750360641.GBP","SG9999001077.SGD","LU0672654240.SGD","LU1181866309.USD","BK4566","LU2452424414.USD","LU1267930730.SGD","LU2468319806.SGD","LU1718418525.SGD","LU2213496289.HKD","LU2433249047.HKD","LU2237443978.SGD","LU1235295455.SGD","LU0648001328.SGD","LU0096364046.USD","LU1935042991.SGD","LU2473716301.USD","LU1989764664.SGD","IE00B19Z3B42.SGD","BK4141","LU0082616367.USD","LU0494093205.USD","BK4527","LU1430594728.SGD","LU1582986433.USD","IE00B7SZLL34.SGD","LU1935042488.USD","LU2023251221.USD","SG9999014542.SGD","IE00BZ199S13.USD","LU0444973449.USD","BK4551","LU0061474960.USD","LU2242650005.HKD","LU1366333091.USD","LU1821325948.USD","LU0960925559.SGD","BK4550","LU1043141123.HKD","LU1670711040.USD","LU0157215616.USD","LU1935042215.USD","RXRX","BK4567","LU0965509010.AUD","IE00BKPKM429.USD","LU1162221912.USD","LU1202635105.USD","BK4609","LU1670627923.USD","LU1712237335.SGD","LU2125154935.USD","LU2054465674.USD","GOOW","IE00BJJMRZ35.SGD","BK4528","LU0557290698.USD","SG9999015341.SGD","LU0238689110.USD","LU1116320737.USD","LU1236620750.USD","SG9999001440.SGD","LU1496350502.SGD","LU0354030511.USD","AALG","LU0757359954.USD","LU0306806265.USD","LU2275660780.HKD","LU0251132253.USD","LU0225283273.USD","LU1032955483.USD","LU2065169927.USD","LU2242649171.HKD","LU1868836591.USD","LU1066051498.USD","LU1093756168.USD","LU1670628061.USD","IE000YTNTUN2.SGD","LU2746668974.SGD","LU0256863902.USD","LU0949170426.SGD","BK4077","LU2458330169.SGD","LU1064131342.USD","LU2360108059.USD","HK0000320223.HKD","IE00B4R5TH58.HKD","LU0353189680.USD","LU2491049909.HKD","LU1868837300.USD","LU1670710588.SGD","LU1941712264.USD","BK4543","LU0289739699.SGD","LU0203347892.USD","LU1934455863.HKD","LU2065171402.SGD","LU2271345857.HKD","LU0965508806.USD","SG9999001424.SGD","LU2491050071.SGD","LU2065170008.USD","IE00BFXG0V08.USD","LU0417517546.SGD","LU0095938881.EUR","LU2210150020.SGD","LU2361044949.HKD","LU0795875169.SGD","LU2265009873.SGD","LU2720916845.USD","LU1720051108.HKD","LU1989764748.USD","LU0545562505.USD","LU2360032135.SGD","LU1548497426.USD","LU0251131958.USD","LU1814569148.SGD","LU1242518931.SGD","LU1564329628.SGD","IE00BJLML261.HKD","LU0203201768.USD","LU1868836914.USD","LU0820562030.AUD","LU1196500208.SGD","LU0786609619.USD","IE0002270589.USD","LU0820561909.HKD","LU0823434740.USD","BK4587","LU0942090050.USD","LU0274383776.USD","SG9999013999.USD","LU1934455194.USD","IE00BK4W5L77.USD","LU0683600562.USD","LU2552382215.SGD","SG9999000418.SGD","BK4561","LU0545039389.USD","LU0345768153.USD","LU1074936037.SGD","LU0648000940.SGD","LU1334329650.SGD","LU0456855351.SGD","LU1670710661.SGD","LU0070302665.USD","DIPS","LU1691799644.USD","LU1316542783.SGD","LU0784385840.USD","LU0912757837.SGD","LU2543165471.USD","LU1506573853.SGD","LU2247934214.USD","LU0314104364.USD","IE00B5TLWC47.USD","LU2168564222.USD","LU0203202063.USD","LU2237957811.SGD","LU2487616109.SGD","OKLS","IE0002141913.USD","LU2592432038.USD","LU1340139317.AUD","LU0314106906.USD","LU0345768740.USD","LU1880398554.USD","NVD3.UK","LU1400636657.SGD","LU2023250843.SGD","IE0009G5SDU7.USD","BK4592","BK4008","LU2098885051.SGD","LU2931357623.SGD","HK0000306701.USD","LU2237438978.USD","LU1989772840.SGD","LU0477156953.USD","LU0251142724.SGD","SG9999015945.SGD","LU0187121727.USD","LU2756315664.SGD","LU1121112475.USD","BK4539","LU1803068623.USD","BK4606","LU1235294995.USD","LU0985320562.USD","LU0079474960.USD","IE0004445015.USD","LU0052756011.USD","LU0162691827.USD","LU2430703095.HKD","NVDX","LU0949170772.SGD","LU0154236417.USD","LU0029864427.USD","LU2764263039.SGD","BK4602","LU1059921491.USD","BOED","LU2063271972.USD","LU0823411888.USD","LULG","LU1267930227.SGD","LU1228905037.USD","LU0276348264.USD","IE00BD6J9T35.USD","LU1917777945.USD","BK4549","LU1037948897.HKD","BOEG","LU1046421795.USD","LU1582987597.SGD","MRK","LU0289941410.SGD","LU0210533765.USD","LU0310800379.SGD","LU2357125470.USD","LU1037948541.HKD","LU0057025933.USD","LU0690374961.EUR","LU2403377893.USD","LU0943347566.SGD","BK4504","LU2505996681.GBP","LU1914381329.SGD","LU0130517989.USD","LU2322448957.HKD","LU0879622024.SGD","LU2083900584.USD","LU0215105999.USD","LU0310800965.SGD","LU0308772762.SGD","LU2237443622.USD","BK4534","LU2462157665.USD","LU2111349929.HKD","IE00BFMHRM44.USD","LU2347655073.USD","LU0210536198.USD","LU2087625088.SGD","LU0757359368.USD","LU2097344357.USD","LU1674673428.USD","LU0957791311.USD","SG9999014914.USD","LU1923623000.USD","IE000W1ABFV2.USD","HK0000914686.HKD","BK4500","IE00BFTCPJ56.SGD","SGXZ31699556.SGD","LU0787776722.HKD","LU0964807845.USD","SDGR","LU2290526834.HKD","LU1435385759.SGD","IE00BLSP4239.USD","LU0211327993.USD","LU0868494708.USD","LU1934455277.USD","HK0000914660.USD","LU2028103732.USD","BK4139","LU1923622614.USD","MRNA","SGXZ57979304.SGD","LU2168563687.JPY","LU0823414551.USD","LU0894485498.HKD","LU2506952097.USD","BK4529","LU2092937148.SGD","LU2125909247.SGD","LU2272731782.SGD","LU2089284900.SGD","GOU","LU0738911758.USD","LU0149725797.USD","LU1582987324.SGD","IE00BFSS8Q28.SGD","LU1720051017.SGD","LU1935043023.USD","LU2746668461.USD","NVDY","IE00BJT1NW94.SGD","MRNY","LU0124676726.USD","LU1642822529.SGD","LU1699723380.USD","NVDW","LU0203345920.USD","LU2106854487.HKD","IE00BQXX3F31.USD","LU0289960550.SGD","IE00BMPRXN33.USD","LU0661504455.SGD","BK4501","LU2430703178.SGD","LU0106261372.USD","LU2298321311.HKD","LU1084165304.USD","SG9999014567.USD","IE0003U64NQ7.SGD","LU0130102774.USD","LU2505996509.AUD","IE0004091025.USD","LU2506951958.HKD","LU0950375773.USD","LU2360106780.USD","LU2236285917.USD","LU2471134796.USD","LU2362541273.HKD","IE00B2B36J28.USD","LU2552382132.HKD","LU0265550359.USD","GB00BDT5M118.USD","LU0980610538.SGD","IE00B19Z8W00.USD","SG9999001176.USD","LU1883839398.USD","LU1988902786.USD","IE00BK4W5M84.HKD","LU1941712348.USD","LU2279689827.SGD","LU0823421416.USD","BK4547","LU0861579265.USD","2NVD.UK","LU0784383803.USD","LU0171293334.USD","LU1127390331.HKD","BK4598","LU2322448791.USD","LU2381873111.SGD","HK0000320264.USD","BK4573","LU2357305700.SGD","NVDD","LU1551013425.SGD","LU0072462426.USD","LU0130518102.USD","LU1791710582.SGD","LU0348723411.USD","LU1804176565.USD","LU0965509283.SGD","LU2552382058.USD","LU0069063385.USD","LU2463028550.USD","LU0265550946.USD","SG9999003800.SGD","LU2087621335.USD","SGXZ99366536.SGD","IE00BYQQ9H92.USD","SGXZ51526630.SGD","LU0823434583.USD","LU0719512351.SGD","LU1623119135.USD","NVD","PFE","LU1732800096.USD","LU2362540622.SGD","LU1861220033.SGD","LU1093756325.SGD","OKLL","LU0889565833.HKD","BK4612","IE00B4JS1V06.HKD","LU1823568750.SGD","LU1645745479.HKD","GOOY","GGLL","LU2272731600.USD","LU1057294990.SGD","LU0321505439.SGD","LU0689472784.USD","IE00B4YYXB79.USD","BK4525","LU0889566641.SGD","LU2286300806.USD","LU0323240290.USD","LU0006306889.USD","LU2097344431.USD","LU2420271590.USD","IE00BJTD4V19.USD","LU1069347547.HKD","LU2092937221.SGD","LU1697837992.HKD","IE00B3SWFQ91.USD","LU2089283258.USD","LU2125909759.SGD","NVDQ","LU0426417589.USD","LU2461242641.AUD","LU2506951875.HKD","LU2168564149.EUR","LU1221951046.USD","HK0000306685.HKD","LU1861127337.USD","LU0426412945.USD","BK4614","LU1989773731.SGD","LU0477156797.USD","BK4579","LU0323239441.USD","LU0128525929.USD","LU1221951129.SGD","LU1571399168.USD","LU2092627202.USD","BK4187","LU1868837136.USD","LU2041044095.USD","LU0965509101.SGD","LU0072461881.USD","MRNX","BK4574","LU0353189763.USD","LU0234572021.USD","LU2250418816.HKD","IE00BZ1G4Q59.USD","LU2404859741.USD","LU2491050154.USD","SG9999011175.SGD","LU0432979614.USD","SGXZ81514606.USD","LU1261432733.SGD","IE00BLSP4452.SGD","LU0985481810.HKD","LU2125154778.USD","LU1894683348.USD","LU2347655156.SGD","SG9999018865.SGD","LU2750360997.AUD","LU0724617625.USD","LU1242518857.USD","LU0868494617.USD","IE00BDCRKT87.USD","LU0476273544.USD","LU0957808578.USD","LU0320765489.SGD","LU0127658192.USD","LU0130103400.USD","LU0345770993.USD","IE00BJTD4N35.SGD","LU0823421333.USD","LU1032466523.USD","LU2168564495.EUR","LU1861215975.USD","IE000ITXATA3.USD","BK4503","LU0345769631.USD","LU1119994496.HKD","IE00BKVL7J92.USD","LU0080751232.USD","LU1582986359.USD","LU1974910355.USD","IE00B3M56506.USD","LU1400636491.USD","LU2112291526.USD","SG9999015358.SGD","BK4605","IE0009356076.USD","LU0302445910.USD","LU1983260115.SGD","LU1674673691.USD","LU0175139822.USD","LU1551013342.USD","LU1992135472.HKD","LU0354030438.USD","VGT","LU0211328371.USD","IE0034235295.USD","LU0345770308.USD","LU0312595415.SGD","IE00BMPRXQ63.HKD","BK4576","SG9999014575.USD","IE00BQXX3D17.EUR","LU1983299246.USD","NVIW.SI","LU1244550221.USD","LU1429558221.USD","LU0109392836.USD","BK4538","BK4581","LU0310799852.SGD","IE00B775H168.HKD","IE0004445239.USD","LU1721428933.USD","LU0472753341.HKD","LU2023250330.USD","LU0289739343.SGD","IE0005OL40V9.USD","LU0210528500.USD","LU0061474705.USD","ANV","BK4588","LU2023250504.SGD","LU0096362180.USD","SG9999015952.SGD","LU0345774631.USD","LU0466842654.USD","LU1989771016.USD","LU2361044865.SGD","IE00B5949003.HKD","LU1880398471.USD","NVDS","LU2244417387.USD","LU2361045086.USD","IE00B7KXQ091.USD","LU0158827781.USD","LU0225771236.USD","LU0642271901.SGD","LU0784385170.HKD","LU2417539215.USD","LU2471134952.CNY","LU0077335932.USD","LU1023059063.AUD","LU0070217475.USD","LU2456880835.USD","LU1989763005.USD","LU0347712357.USD","LU0726765562.USD","MSFY","LU0107464264.USD","LU0882574139.USD","SG9999018857.SGD","LU0792757196.USD","LU1935043536.SGD","LU1791710400.SGD","LU2237443549.SGD","MSFL","IE00BMPRXR70.SGD","GOOP","LU0444971666.USD","BK4167","BOEU","LU1564329115.USD","IE00BJJMRY28.SGD","LU0788109477.HKD","LU1951200564.SGD","IE000M9KFDE8.USD","LU1852331112.SGD","BK4532","LU0211326839.USD","LU0306807586.USD","LU0640476718.USD","GGLS","LU1564329461.SGD","LU2324357040.USD","LU2404859667.USD","IE00B3S45H60.SGD","BK4202","LU0011850046.USD","LU1732799900.SGD","LU1815333072.USD","LU2249611893.SGD","LU0211326755.USD","IE00BDRTCR15.USD","LU2272731865.HKD","LU0208291251.USD","LU1145028129.USD","GB00B4QBRK32.GBP","BK4548","LU0289961442.SGD","LU0094547139.USD","LU1066051811.HKD","LU1069344957.HKD","LU2125909593.SGD","SG9999015978.USD","LU0323591593.USD","LU0511384066.AUD","BK4559","LU2413666426.HKD","BK4514","LU0098860793.USD","LU0528227936.USD","LU0256863811.USD","LU0994945656.USD","LU1267930573.SGD","SG9999017495.SGD","LU1868836757.USD","SGXZ23171101.USD","IE0004086264.USD","BK4554","BK4564","LU0170899867.USD","LU1894683264.USD","LU0823417653.USD","LU2237957902.USD","LU0894486033.HKD","LU2360107168.USD","LU0823414478.USD","LU1066053197.SGD","LU0267386448.USD","LU0109391861.USD","LU1066051225.USD","IE00BN8TJ469.HKD","LU2125909916.SGD","LU2133065610.SGD","SG9999004303.SGD","LU0784384876.USD","LU1496350171.SGD","NVD2.UK","LU1201861165.SGD","LU1232071149.USD","LU0058720904.USD","LU1585245621.USD","BK4535","LU1670711123.USD","LU0081259029.USD","LU1043141396.HKD","LU1035775433.USD","LU1267930813.SGD","LU1236620834.HKD","LU2264538146.SGD","LU0496365809.HKD","LU2506951792.HKD","LU0342679015.USD","SG9999002232.USD","IE0001KFT4U8.USD","LU2089985449.USD","GOOX","LU2237443895.HKD","LU2237443465.HKD","LU1366192091.USD","LU0690374615.EUR","IE00B19Z3581.USD","LU2756315318.SGD","LU2471134879.HKD","LU1923622291.USD","LU2108987350.USD","LU1992135399.USD","LU2294711713.HKD","LU2191332357.HKD","LU2860962120.EUR","IE000KEQY171.SGD","LU0056508442.USD","LU1116320901.HKD","LU1301847155.USD","LU1929549753.HKD","LU0345769128.USD","LU1244550494.USD","SNVD.UK","MSFX","LU1323610961.USD","GB00B4LPDJ14.GBP","LU2413666699.HKD","LU0316494557.USD","LU2896262040.SGD","LU1228905540.USD","LU0061475181.USD","LU1803068979.SGD","BK4081","3NVD.UK","LU0225284248.USD","LU1564329032.USD","LU0048584097.USD","IE00BKDWB100.SGD","LU0795875086.SGD"],"gpt_icon":1},{"id":"2620491059","title":"Crispr Therapeutics Completes $600 Million Convertible Notes Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2620491059","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620491059?lang=en_us&edition=fundamental","pubTime":"2026-03-17 04:34","pubTimestamp":1773693281,"startTime":"0","endTime":"0","summary":"Crispr Therapeutics AG ( ($CRSP) ) just unveiled an announcement. On March 16, 2026, CRISPR Therapeutics AG completed a $600 million private offeri...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/crispr-therapeutics-completes-600-million-convertible-notes-offering?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/crispr-therapeutics-completes-600-million-convertible-notes-offering?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","CRSP","BK4556","BK4539","LU1861559042.SGD","BK4139","BK4007","BK4611","LENZ","BK4585","LU1861558580.USD"],"gpt_icon":0},{"id":"2619961469","title":"Analysts Are Bullish on These Healthcare Stocks: Beam Therapeutics (BEAM), Pelthos Therapeutics (PTHS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2619961469","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619961469?lang=en_us&edition=fundamental","pubTime":"2026-03-16 21:50","pubTimestamp":1773669007,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Beam Therapeutics (BEAM – Research Report), Pelthos ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-beam-therapeutics-beam-pelthos-therapeutics-pths-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-beam-therapeutics-beam-pelthos-therapeutics-pths-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4535","BK4137","BK4139","BK4505","PTHS","BK4112","BK4611","BEAM","LABU","BLSG","LU1861558580.USD","BK4585","LU0029874061.USD","BLSX","LU1861559042.SGD","BK4556","BK4581","BK4588","XBI","LU0128526141.USD"],"gpt_icon":0},{"id":"2619634904","title":"HCW Biologics Announces Positive Research Results for CAR-T Cell Therapy Manufactured Utilizing Its Commercial-Ready Proprietary Compound, HCW9206, Published in Science Advances","url":"https://stock-news.laohu8.com/highlight/detail?id=2619634904","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619634904?lang=en_us&edition=fundamental","pubTime":"2026-03-16 20:00","pubTimestamp":1773662400,"startTime":"0","endTime":"0","summary":"Commercialization ready compound supports a new method of generating highly functional human CAR-T cells for treating infectious diseases and cancer In experimental models, human CAR-T cells manufactu","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/16/3256197/0/en/HCW-Biologics-Announces-Positive-Research-Results-for-CAR-T-Cell-Therapy-Manufactured-Utilizing-Its-Commercial-Ready-Proprietary-Compound-HCW9206-Published-in-Science-Advances.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4611","BK4121","BK4139","TEMT","HCWB","LU1861559042.SGD","BK4613","LU1861558580.USD","BK4230","BK4022"],"gpt_icon":0},{"id":"2619912669","title":"CRISPR Therapeutics’ CASGEVY Progress Reframes Growth And Valuation Story","url":"https://stock-news.laohu8.com/highlight/detail?id=2619912669","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619912669?lang=en_us&edition=fundamental","pubTime":"2026-03-14 18:21","pubTimestamp":1773483682,"startTime":"0","endTime":"0","summary":"CRISPR Therapeutics (NasdaqGM:CRSP) reports strong commercial progress for its gene editing therapy CASGEVY, with higher than expected revenue contribution.\nThe company highlights a threefold increase in projected patient initiations for 2025, signaling growing real world adoption of CASGEVY.\nAlongside CASGEVY traction, CRISPR Therapeutics advances new gene editing programs and partnerships, expanding its clinical pipeline.\n\nCRISPR Therapeutics, trading at $48.75, is moving further into a...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-crsp/crispr-therapeutics/news/crispr-therapeutics-casgevy-progress-reframes-growth-and-val","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-crsp/crispr-therapeutics/news/crispr-therapeutics-casgevy-progress-reframes-growth-and-val","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4611","LU1861558580.USD","LU2065732104.USD","CRSP","BK4556","PRGS","BK4588","BK4139","BK4585","LU1861559042.SGD","BK4097"],"gpt_icon":0},{"id":"2619110236","title":"Press Release: Morningstar, Inc. Declares Quarterly Dividend of 50 Cents Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2619110236","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619110236?lang=en_us&edition=fundamental","pubTime":"2026-03-14 04:15","pubTimestamp":1773432900,"startTime":"0","endTime":"0","summary":"The board of directors of Morningstar, Inc. , a leading provider of independent investment insights, today declared a quarterly dividend of 50 cents per share, consistent with the dividend paid in January. The dividend is payable April 30, 2026, to shareholders of record as of April 3, 2026. Please contact investors@morningstar.com with any questions.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CRSP","MORN","LU1861558580.USD","LU1878469433.USD","BK4598","BK4588","LU1861559042.SGD","BK4112","BK4585","BK4556","LU2065731478.USD","BK4611"],"gpt_icon":0},{"id":"2619152838","title":"Assessing Tempus AI (TEM) Valuation As New Oncology Study Highlights Clinical Impact Of Its AI Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2619152838","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619152838?lang=en_us&edition=fundamental","pubTime":"2026-03-13 10:25","pubTimestamp":1773368710,"startTime":"0","endTime":"0","summary":"Tempus AI (TEM) is back in focus after publishing a JCO Precision Oncology study showing its advanced comprehensive genomic profiling tools identified actionable cancer treatment options that standard in network tests missed for about 12% of patients.\nSee our latest analysis for Tempus AI.\nThe study arrives after a busy few weeks, with Tempus AI striking an expanded multi year collaboration with Merck and a new alliance with NYU Langone Health. Yet the share price has seen a 29.85% 90 day...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tem/tempus-ai/news/assessing-tempus-ai-tem-valuation-as-new-oncology-study-high","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tem/tempus-ai/news/assessing-tempus-ai-tem-valuation-as-new-oncology-study-high","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1861559042.SGD","BK4528","BK4613","BK4611","BK4551","BK7095","BK4585","BK4588","BK4543","BK4587","AIYY","LU1861558580.USD","TEMT","BK4121","TEM","BK4023"],"gpt_icon":1},{"id":"2619597111","title":"Cathie Wood Invests Over $10M in CRISPR and PAYP Stocks, Trims Stakes in TER and IONS","url":"https://stock-news.laohu8.com/highlight/detail?id=2619597111","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619597111?lang=en_us&edition=fundamental","pubTime":"2026-03-13 10:12","pubTimestamp":1773367952,"startTime":"0","endTime":"0","summary":"Cathie Wood’s ARK Invest ETFs (exchange-traded funds) made several notable portfolio moves on Thursday, March 12, according to the firm’s daily tra...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/cathie-wood-invests-over-10m-in-crispr-and-payp-stocks-trims-stakes-in-ter-and-ions?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/cathie-wood-invests-over-10m-in-crispr-and-payp-stocks-trims-stakes-in-ter-and-ions?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1861559042.SGD","LU0957808578.USD","BK4147","IE00BN0W2V16.EUR","IONS","ARKK","TERG","ARKW","BK4611","LU0444971666.USD","LU1861558580.USD","BK4543","IE00BN0W2T93.GBP","BK4548","BK4588","ARKQ","BK4585","IE00BN0W2W23.USD","CRSP","BK4139","ARKX","BK4544","BK4556","TER","LU1642822529.SGD","LU1815336760.USD","PAYP","ARKF","ARKG"],"gpt_icon":0},{"id":"2618900073","title":"A Look At Recursion Pharmaceuticals (RXRX) Valuation After Q4 Beat And AI Clinical Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2618900073","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618900073?lang=en_us&edition=fundamental","pubTime":"2026-03-12 14:21","pubTimestamp":1773296482,"startTime":"0","endTime":"0","summary":"Recursion Pharmaceuticals (RXRX) has drawn fresh attention after reporting Q4 revenue above consensus, highlighting progress in its AI-native drug discovery platform and a cash runway that management says extends into early 2028.\nSee our latest analysis for Recursion Pharmaceuticals.\nDespite the strong Q4 update and progress across its AI-native programs, Recursion Pharmaceuticals’ share price return has been weak, with a 30 day share price return decline of 10.39% and a 1 year total...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rxrx/recursion-pharmaceuticals/news/a-look-at-recursion-pharmaceuticals-rxrx-valuation-after-q4","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rxrx/recursion-pharmaceuticals/news/a-look-at-recursion-pharmaceuticals-rxrx-valuation-after-q4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4097","RXRX","BK4611","BK4587","BK4139","BK4543","BK4551","BK4548","BK4528","BK4585","AI","BK4609","BK4023","AIYY","BK4588","BK4539","LU2065732104.USD"],"gpt_icon":0},{"id":"2618979957","title":"Recursion Pharmaceuticals CEO and President Najat Khan Disposes of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2618979957","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618979957?lang=en_us&edition=fundamental","pubTime":"2026-03-12 05:42","pubTimestamp":1773265320,"startTime":"0","endTime":"0","summary":"Najat Khan, CEO and President and a director of Recursion Pharmaceuticals Inc., reported a disposal of the company’s Class A common stock. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Recursion Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 11, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260311:nNDL4mhvTG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Recursion Pharmaceuticals CEO and President Najat Khan Disposes of Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4609","BK4139","BK4611","RXRX","BK4539","BK4548"],"gpt_icon":0},{"id":"2618925285","title":"Why Tempus AI Stock Is Up Wednesday?","url":"https://stock-news.laohu8.com/highlight/detail?id=2618925285","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618925285?lang=en_us&edition=fundamental","pubTime":"2026-03-11 22:39","pubTimestamp":1773239940,"startTime":"0","endTime":"0","summary":"Tempus AI shares are trading higher Wednesday after Needham analyst Ryan MacDonald reiterated a Buy rating and maintained a $75 price target.","market":"sh","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/03/11/The-Tempus-AI-Trade.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/03/11/The-Tempus-AI-Trade.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/trading-ideas/movers/26/03/51188952/why-tempus-ai-stock-is-up-wednesday","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/trading-ideas/movers/26/03/51188952/why-tempus-ai-stock-is-up-wednesday","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4611","BK4585","BK4551","TEMT","BK4528","AI","BK4543","LU1861558580.USD","BK4121","TEM","BK4023","BK4588","BK4587","AIYY","LU1861559042.SGD","BK4613"],"gpt_icon":1},{"id":"2618594070","title":"CRSP, SOLQ: Cathie Wood’s ARK ‘Buys the Dip’ in CRISPR and Solana Staking ETF","url":"https://stock-news.laohu8.com/highlight/detail?id=2618594070","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618594070?lang=en_us&edition=fundamental","pubTime":"2026-03-11 21:10","pubTimestamp":1773234600,"startTime":"0","endTime":"0","summary":"Cathie Wood’s ARK Invest ETFs (exchange-traded funds) made targeted buys in biotech and cryptocurrency sectors on Tuesday, March 10, capitalizing o...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/crsp-solq-cathie-woods-ark-buys-the-dip-in-crispr-and-solana-staking-etf?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/crsp-solq-cathie-woods-ark-buys-the-dip-in-crispr-and-solana-staking-etf?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARKK","ARKQ","BK4588","FDN","CRSP","ARKX","ARKG","LU1861558580.USD","SOLT","BK4585","BK4544","BK4611","BK4139","BK4550","LU1861559042.SGD","BK4556"],"gpt_icon":0},{"id":"2618942069","title":"Tempus AI study finds 12% of community oncology patients gain actionable results from advanced genomic profiling features","url":"https://stock-news.laohu8.com/highlight/detail?id=2618942069","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618942069?lang=en_us&edition=fundamental","pubTime":"2026-03-11 20:31","pubTimestamp":1773232260,"startTime":"0","endTime":"0","summary":"Tempus reported a clinical study published in JCO Precision Oncology evaluating advanced features of comprehensive genomic profiling in community oncology settings. The study was conducted with The Oncology Institute and assessed tumor-normal matched sequencing, RNA sequencing, and liquid biopsy reflex testing. Across pilot and expanded cohorts, 12% of patients had potentially actionable findings tied to an approved therapy that were identified only through these advanced profiling features. The announcement did not state that results were previously presented or scheduled for future presentation.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260311:nNDL2bgzhY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4613","TOI","TEM","LU1861558580.USD","TEMT","BK4121","BK4185","BK4611","LU1861559042.SGD"],"gpt_icon":1}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":32,"code":"91000000","status":"200"}]}}